Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BrightSpring Health Services (BTSG) Cost of Revenue (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Cost of Revenue for 3 consecutive years, with $236.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 9.64% year-over-year to $236.6 million, compared with a TTM value of $885.4 million through Dec 2025, up 11.05%, and an annual FY2025 reading of $885.4 million, up 11.05% over the prior year.
  • Cost of Revenue was $236.6 million for Q4 2025 at BrightSpring Health Services, up from $220.8 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $3.1 billion in Q2 2023 and bottomed at -$2.3 billion in Q3 2023.
  • Average Cost of Revenue over 3 years is $199.5 million, with a median of $213.7 million recorded in 2024.
  • Peak annual rise in Cost of Revenue hit 148.04% in 2024, while the deepest fall reached 93.73% in 2024.
  • Year by year, Cost of Revenue stood at -$449.2 million in 2023, then skyrocketed by 148.04% to $215.8 million in 2024, then rose by 9.64% to $236.6 million in 2025.
  • Business Quant data shows Cost of Revenue for BTSG at $236.6 million in Q4 2025, $220.8 million in Q3 2025, and $216.4 million in Q2 2025.